Novabay(NBY)05-10 04:25
$Novabay(NBY)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-24-015679 Act: 34 Size: 10 MB 网页链接查看全文
智通财经APP获悉,美股周一盘前,NovaBay(NBY.US)发布了2019Q2财报,该生物制药公司专注于将 Avenova 商业化用于国内眼部护理市场。 根据财报,期内,公司净销售额为180万美元;Avenova销售额为160万美元,环比增长9%。 该公司总裁兼首... 网页链接
格隆汇6月11日丨NovaBay(NBY)今日盘前涨39.03%,报6.31美元,昨日大涨874.84%。NovaBay是一家专注眼部护理市场的生物制药公司,专注于其非抗生素抗感染产品的商业化和开发,以满足全球局部抗感染市场尚未得到满足的治疗需求,其主推产品之一... 网页链接
5月10日Novabay制药(股票代码:NBY)公布财报,公告显示公司2018财年第一财季净利润为-215.00万美元,同比增长46.4%;营业收入为294.70万美元,同比下跌20.37%。 NovabayPharmaceutic ... 网页链接
$NovaBay Pharmaceuticals, Inc.(NBY)$ S-1 - General form for registration of securities under the Securities Act of 1933 Filed: 2017-12-15 AccNo: 0001437749-17-020791 Size: 1 MB 网页链接
$NovaBay Pharmaceuticals, Inc.(NBY)$ 8-K - Current report Filed: 2017-12-12 AccNo: 0001437749-17-020566 Size: 19 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 网页链接
$NovaBay Pharmaceuticals, Inc.(NBY)$ DEF 14A - Other definitive proxy statements Filed: 2017-12-05 AccNo: 0001437749-17-020184 Size: 809 KB 网页链接
$NovaBay Pharmaceuticals, Inc.(NBY)$ 8-K - Current report Filed: 2017-11-28 AccNo: 0001437749-17-019876 Size: 93 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem ...
$NovaBay Pharmaceuticals, Inc.(NBY)$ PRE 14A - Other preliminary proxy statements Filed: 2017-11-22 AccNo: 0001437749-17-019750 Size: 814 KB 网页链接
$NovaBay Pharmaceuticals, Inc.(NBY)$ 8-K - Current report Filed: 2017-11-21 AccNo: 0001437749-17-019678 Size: 239 KBItem 1.01: Entry into a Material Definitive AgreementItem 3.02: Unregistered Sales of Equity SecuritiesItem 9.01: Financial Statements and Exhibits 网页链接
$NovaBay Pharmaceuticals, Inc.(NBY)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-11-14 AccNo: 0001437749-17-019354 Size: 7 MB 网页链接
$NovaBay Pharmaceuticals, Inc.(NBY)$ 美东时间 2017-11-14 盘后 披露财报,预期EPS -0.09 网页链接
$NovaBay Pharmaceuticals, Inc.(NBY)$ 8-K - Current report Filed: 2017-09-20 AccNo: 0001437749-17-016093 Size: 17 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 网页链接
$NovaBay Pharmaceuticals, Inc.(NBY)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-08-10 AccNo: 0001437749-17-014419 Size: 7 MB 网页链接